Albumin & Creatinine Tests Market Size & Share, by Product (Analyzers, Cartridges (PoC, Tabletop), Dipsticks, Kits, Reagents); Type (Blood & Urine Creatinine, Urine Albumin, Glycated Albumin); End-user (Hospital, Diagnostic & Research Labs) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 4665
  • Published Date: Jan 30, 2023
  • Report Format: PDF, PPT

Companies Dominating the Albumin & Creatinine Tests Landscape

    • RayBiotech Life, Inc.

      • Company Overview

      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Danaher Corporation
    • FUJIFILM Wako Pure Chemical Corporation
    • Nova Biomedical
    • Ortho Clinical Diagnostics
    • PromoCell GmbH
    • Siemens Healthineers company
    • Sysmex Corporation
    • Teco Diagnostics
    • Thermo Fisher Scientific Holdings, Inc.

Browse Key Market Insights with Data Illustration:


In The News

  • Sysmex Corporation introduced a new product named as UF-1500 Fully Automated Urine Particle Analyzer (UF-1500). The UF-1500 is a new product that automates the process of testing urine sediments. This will allow for faster and more accurate results.

  • Siemens Healthcare GmbH declared the global OEM partnership to enhance patient monitoring with chronic kidney diseases. Using Healthy. Io's smartphone-based urinalysis system, the company's urinalysis reagents allow patients to conduct home testing

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 4665
  • Published Date: Jan 30, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Rising rates of hypoalbuminemia and hypovolemia and the rising geriatric population are the major factors driving the market growth.

The market is anticipated to attain a CAGR of 19% over the forecast period, i.e., 2023-2035.

The increased price of the automated analyzer and the lack of accuracy of the test are estimated to be the growth hindering factors for the market expansion.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are RayBiotech Life, Inc., Danaher Corporation, FUJIFILM Wako Pure Chemical Corporation, Nova Biomedical, Ortho Clinical Diagnostics, PromoCell GmbH, Siemens Healthineers, Sysmex Corporation, Teco Diagnostics, Thermo Fisher Scientific Holdings, Inc.

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product, type, end-user, and by region.

The urine albumin segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying